Press Releases
Press Releases
Phase 2 Interim Data Show High Objective Response Rate for Patients Treated with Elotuzumab plus
Abbott and Bristol-Myers Squibb Company announced interim results from the Phase 2 portion of a Phase 1b/2 open-label study which showed a high objective response rate (ORR) among patients with relapsed multiple myeloma who received elotuzumab plus lenalidomide and...
Press Releases
FDA Advisory Committee Recommends Approval to Expand Use of LAP-BAND® Adjustable Gastric Banding System for Obese Adults
Allergan, Inc. announced the US FDA Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee has recommended with an 8-2 vote that the FDA extend the currently approved use of the LAP-BAND® System, Allergan's gastric band, on...
Press Releases
Next-Generation Cell Sorter from Beckman Coulter Enables Multi-Color Flow Cytometry Studies
MoFlo Astrios next-generation cell sorter from Beckman Coulter, Inc. leverages the stable fluidic design of the original MoFlo and the electronic processing of the MoFlo XDP, while expanding sorting capabilities with an array of laser options. A range of...
Press Releases
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
Baxter International Inc. and Takeda Pharmaceutical Company Limited announced that the parties have completed a Development, License and Technology Transfer Agreement. Under the terms of the agreement, Takeda and Baxter will expand upon their previously announced collaboration to bring...
Press Releases
Life Technologies Wins Top Ten Innovations of the Year Award
LifeTechnologies Corporation announced that its Applied Biosystems Attune(TM) Acoustic Focusing Cytometer has been named one of the Top Ten Innovations of 2010 by The Scientist Magazine. On an annual basis for the past three years, the publication gathers a...
Press Releases
Selcia and Gilead Sciences Extend Liver Disease Drug Discovery Collaboration
Selcia Limited, a leading contract research organisation, announced a drug discovery collaboration agreement with Gilead Sciences, Inc. Building on an established partnership following significant progress made to date, Selcia’s chemists and biologists will continue to provide integrated drug discovery...
Press Releases
Micell Technologies Enrolls First Patient in DESSOLVE I First-In-Human Study of MiStent DES
Micell Technologies,announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries),...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read